Search Options Stock News and Analysis from Schaeffer's

Morgan Stanley Double Upgrade Blows BIIB Out of the Water

https://www.schaeffersresearch.com/content/news/2020/07/27/morgan-stanley-double-upgrade-blows-biib-out-of-the-water

7/27/2020 10:36 AM

Pharmaceutical name Biogen Inc (NASDAQ:BIIB) is soaring today, up 4.2% to trade at $283.89, on a double upgrade from Morgan Stanley. The analyst lifted its rating to "overweight" from "underweight" a...

Biogen Stock Moves Higher After Q2 Earnings Beat

https://www.schaeffersresearch.com/content/news/2020/07/22/biogen-stock-moves-higher-after-q2-earnings-beat

7/22/2020 10:06 AM

The shares of Biogen Inc (NASDAQ: BIIB) are up 1.8% at $285.23 this morning, after the multinational biotechnology company reported second-quarter profits of $10.26 per share on 3.68 billion in revenu...

Biogen Stock Surges on Alzheimer's Treatment FDA Application

https://www.schaeffersresearch.com/content/news/2020/07/08/biogen-stock-surges-on-alzheimers-treatment-fda-application

7/8/2020 9:57 AM

Biopharmaceutical concern Biogen Inc (NASDAQ:BIIB) is up 7.8% to trade at $289.18 this morning, after the company submitted a marketing application to the Food and Drug Administration (FDA) regarding...

BIIB Stock Brushes Off Bull Note

https://www.schaeffersresearch.com/content/news/2020/01/08/biib-stock-brushes-off-bull-note

1/8/2020 10:37 AM

Biopharmaceutical concern Biogen Inc (NASDAQ:BIIB) is slightly lower today, despite joining Behind the Seizure, along with a number of other companies, which works to provide faster diagnosis to chil...

Biogen Stock Up On Buyback, Bull Note

https://www.schaeffersresearch.com/content/news/2019/12/20/biogen-stock-up-on-buyback-bull-note

12/20/2019 10:09 AM

The shares of Biogen Inc (NASDAQ:BIIB) are up 0.9% to trade at $300.18 this morning, after the drugmaker announced a $5 billion share repurchase program. This is the second $5 billion stock buyback Bi...

PEOPLE ALSO SEARCH FOR

-intraday-options-activity